We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.38% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Paysign
PAYS
$707M
| – | – |
-78,298
| Closed | -$125K |
|
3827
Pembina Pipeline
PBA
$27.8B
| – | – |
-27,900
| Closed | -$848K |
|
3828
Petrobras
PBR
$118B
| – | – |
-1,375,858
| Closed | -$15.1M |
|
|
3829
Petrobras Class A
PBR.A
$106B
| – | – |
-229,568
| Closed | -$2.32M |
|
3830
Puma Biotechnology
PBYI
$449M
| – | – |
-396,967
| Closed | -$1.21M |
|
3831
Pacira BioSciences
PCRX
$974M
| – | – |
-205,322
| Closed | -$12.4M |
|
3832
PDF Solutions
PDFS
$2.01B
| – | – |
-46,744
| Closed | -$1.49M |
|
3833
PetMed Express
PETS
$42.1M
| – | – |
-46,357
| Closed | -$1.17M |
|
3834
TDH Holdings
PETZ
$17.4M
| – | – |
-2,451
| Closed | -$189K |
|
3835
CALL
Procter & Gamble
PG
$340B
| – | – |
-7,900
| Closed | -$1.29M |
|
|
3836
PUT
Procter & Gamble
PG
$340B
| – | – |
-600
| Closed | -$98K |
|
3837
Progressive
PGR
$124B
| – | – |
-74,763
| Closed | -$7.67M |
|
3838
Progyny
PGNY
$2.14B
| – | – |
-46,768
| Closed | -$2.35M |
|
3839
Pultegroup
PHM
$24.8B
| – | – |
-26,803
| Closed | -$1.53M |
|
3840
Impinj
PI
$5.39B
| – | – |
-34,549
| Closed | -$3.06M |
|
3841
Pinterest
PINS
$13.8B
| – | – |
-580,483
| Closed | -$21.1M |
|
3842
Invesco Pharmaceuticals ETF
PJP
$501M
| – | – |
-922
| Closed | -$75K |
|
3843
Parke Bancorp
PKBK
$403M
| – | – |
-1,701
| Closed | -$36K |
|
3844
Park Aerospace
PKE
$801M
| – | – |
-21,422
| Closed | -$283K |
|
3845
Planet Labs
PL
$8.23B
| – | – |
-234,638
| Closed | -$1.44M |
|
3846
Planet Fitness
PLNT
$3.7B
| – | – |
-4,638
| Closed | -$421K |
|
3847
Playtika
PLTK
$1.07B
| – | – |
-497,530
| Closed | -$8.6M |
|
|
PLYM
3848
DELISTED
Plymouth Industrial REIT
PLYM
| – | – |
-17,846
| Closed | -$571K |
|
3849
PharmaCyte Biotech
PMCB
$5.86M
| – | – |
-13,515
| Closed | -$35K |
|
3850
CPI Card Group
PMTS
$330M
| – | – |
-13,501
| Closed | -$250K |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.